ArticleProceedings of SPIE--the International Society for Optical Engineering
Analysis of digital noise and reduction methods on classifiers used in automated visual evaluation in cervical cancer screening.
Article in Proceedings of SPIE--the International Society for Optical Engineering. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 3 citations in OpenAlex.
- Data Characterization for Reliable AI in Medicine.Recent trends in image processing and pattern recognition : 5th International Conference, RTIP2R 2022, Kingsville, TX, USA, December 01-02, 2022, revised selected papers. International Conference on Recent Trends in Image Processing and... · 2023Article
- Image Quality Classification for Automated Visual Evaluation of Cervical Precancer.Medical image learning with limited and noisy data : first international workshop, MILLanD 2022, held in conjunction with MICCAI 2022, Singapore, September 22, 2022, proceedings. MILLanD (Workshop) (1st : 2022 : Singapore) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
Abstract
The burden of cervical cancer disproportionately falls on low- and middle-income countries (LMICs). Automated visual evaluation (AVE) is a technology being considered as an adjunct tool for the management of HPV-positive women. AVE involves analysis of a white light illuminated cervical image using machine learning classifiers. It is of importance to analyze various impacts of different kinds of image degradations on AVE. In this paper, we report our work regarding the impact of one type of image degradation, Gaussian noise, and one of its remedies we have been exploring. The images, originated from the Natural History Study (NHS) and ASCUS-LSIL Triage Study (ALTS), were modified by the addition of white Gaussian noise at different levels. The AVE pipeline used in the experiments consists of two deep learning components: a cervix locator which uses RetinaNet (an object detection network), and a binary pathology classifier that uses the ResNeSt network. Our findings indicate that Gaussian noise, which frequently appears in low light conditions, is a key factor in degrading the AVE's performance. A blind image denoising technique which uses Variational Denoising Network (VDNet) was tested on a set of 345 digitized cervigram images (115 positives) and evaluated both visually and quantitatively. AVE performances on both the synthetically generated noisy images and the corresponding denoised images were examined and compared. In addition, the denoising technique was evaluated on several real noisy cervix images captured by a camera-based imaging device used for AVE that have no histology confirmation. The comparison between the AVE performances on images with and without denoising shows that denoising can be effective at mitigating classification performance degradation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.